Why the study?
Does D- and DL-sotalol affect action potential duration differently in guinea-pig versus human atrial tissues?
Does D- and DL-sotalol affect action potential duration differently in guinea-pig versus human atrial tissues?
The study demonstrates a differential sensitivity to sotalol between human and guinea-pig atrium, explaining sotalol's clinical ability to prolong atrial monophasic action potential duration.
Species differences in sotalol atrial effects limit guinea-pig model utility; leaves open human ion-channel mechanisms for targeted study.
The effects of racemic DL-sotalol and D-sotalol on guinea-pig sino-atrial node, atrium and ventricle and on human atrium were studied using standard microelectrode techniques. Both compounds increased spontaneous sinus node cycle length largely by prolonging the repolarization phase of the action potentials. This effect was attributed to blockade of outward potassium current. Ventricular action potential duration was similarly prolonged by DL-sotalol at concentrations of 5-50 microM. DL-Sotalol 1-50 microM had no effect on guinea-pig atrial action potential duration and D-sotalol produced minor prolongation only at the highest concentration (50 microM). Human atrial action potentials were, however, significantly prolonged by both DL- and D-sotalol 10 microM. This indicates differential sensitivities to sotalol for human and guinea-pig atrium and explains the ability of sotalol to prolong atrial monophasic action potential duration in clinical studies.
No takes yet. Share an insight, caveat, or question.
Terence J. Campbell (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from British Journal of Pharmacology